All episodes
Instagram Post that Sparked FDA Warning Letter
Why Are So Many Doctors Getting Arrested?
How to Run Compliant Pharma Speaker Programs
Are You Picking the Wrong KOLs?
How KLF’s Client Base Evolved Over 20 Years
FDA Pushback on Accelerated Gene Therapy Approvals
Your DEI Program Could Trigger an FCA Case
Teva’s Charity Partnership Scrutinized
Is There a “Right” Way to Calculate FMV?
Can Non-Physicians Own Clinical Trial Sites?
The KLF Story You Haven’t Heard
Why Telehealth Platforms Are Getting Sued
Should Clinical Trial Sites Be Paid Differently?
How to Build an AI Compliance Program
What the Big Beautiful Bill Means for Trial Sites
Co-Pay Mistakes Can Trigger DOJ Action
NIH Grant Denials Ruled Discriminatory?
Are Speaker programs supposed to be salesy?
DTP Compliance Just Got Tricky
Should You Use AI to Draft Informed Consent?
Could You Survive a Surprise Pharmacy Audit?
Self-Reporting in Clinical Trials
$14M Fine Says This “Free” Offer Wasn’t Legal
Nonprofit Pharma Exists. Here is how it works
FTC Rules for Pharma Companies
Whistleblowing in Clinical Trials: Is It Worth the Risk?
The Right Way to Do Medical Affairs on LinkedIn
Are We Paying Clinical Trial Patients Enough?
Pharma Ads Are Getting Canceled
Unpacking Screen Fail Payments in Research
Post-Trump Antitrust Rules Are Crushing Pharma Deals
7 Must-Know Steps to transfer medical device ownership
Responding to Site Findings
Is Your Medical Website Illegal?
Price Fixing in Clinical Research
DOJ Cracks Down on Pharmacy Fraud
Protect Your DTP Strategy
AI Clinical Trial Negotiators
SOPs: How Many is Too Many?
Is DTP Pharma’s Next Big Move?
Hackers Are Stealing Your Personal Health Data
How a “Medical Education” Program Became a $202M Fraud
Webinar Recap: What Sponsors Must Know About Fraud
AI-Powered Engagement is a Minefield
Webinar Update: Fraud Prevention Strategies Every Sponsor Needs
Are Your Promotional Claims Putting Your Company at Risk?
Privacy Dangers Lurking in Clinical Trial Mergers
The FDA's Crisis Is Now Your Problem
Broken FDA, Big Consequences
You are now the Healthcare Provider - The Future of Health Insurance: Trends, Challenges, and Innovations
Essential Due Diligence Steps for Clinical Research M&A
Is AI Telemarketing Strategy Illegal?
No Clinical Trial Waste
The Real Meaning of Audit-Readiness in Clinical Research
Ordinary People Are Changing Medicine
Investor Influence Can Trigger FCA Violations
Sponsor to Organization vs. Direct Investigator Agreements: Pros & Cons
Clinical Trial Site M&A: What Most Get Wrong
Future-Proof Sites: SOS Insights Revealed
Why Food M&A Deals Collapse—And How to Prevent It
Non-Compliance Led to QOL Medical's $47M Settlement
FDA Regulatory Submissions: Challenges, Trends, and Future Predictions
How to do a VR promo check - Carly Schaecter gives us her advice
Diversity Matters in Clinical Trials
EMA’s LLM Guidelines Impact Life Sciences
How to Network Like a Pro at Conferences
Getting Ready for SOS 2025: FDA 483s, SOPs, and Site Survival
Maximizing Site Value
5 Key Areas to Review in Clinical Trial Agreements
Discussing Stem Cell Research Opportunities with a Research Site Owner
Quality Management: A Must in Clinical Trial Contracts
AI-Powered Chatbots in Pharma Sales and Education
Will New Tariffs Disrupt Your Next Pharma Deal?
Protecting Patient Data in a Changing Regulatory Landscape
Off-Label Promotion Changes in 2025
Turning Physicians into Leaders
Key Regulatory Agencies in Pharma M&A
Does E6 (R3) Blur the Line Between GCP and Privacy Laws?
RFK Jr. Confirmed as HHS Secretary: What It Means for Healthcare Policy
America’s Research Future in Jeopardy
Trump Administration’s NIH cuts: Will they cripple US medical research?
DEI Under Trump: What It Means for Clinical Trials
CAPA & RCA: A Must for Pharma M&A
Trump Targets Indirect Costs in NIH Funding
The USAID Halt and Its Consequences for Clinical Research
Ebola Vaccine Trial in Record Time!
Your Clinical Trial Site M&A Agreement is Exposing You to Risk
What Does ICH E6 R3 Say About Returning Data to Participants?
Navigating the Ongoing HHS Communication Freeze
Ordinary People Are Changing Medicine
Trump’s First 10 Days: The Impact on Clinical Trials
Selling a Business with Issues
Breaking Down GCP E6(R3)
AdvaMed 7 rules for Essential AI Innovation
Teva’s Case Should Shape Your Pharma Strategy
AI’s Impact on Healthcare: Liability, Ethics, and Responsibility
Four Types of Research related Grant Fraud
Defining Scope in Due Diligence Transactions
Clinical Trial Checklist
Presidential Changes and Impact on Drug Related Misinformation